In particular, we have demonstrated for the first time the protective role of FGF1 in MCF-7 breast cancer cells against cytotoxicity induced by taltobulin, which is mediated by the activation of FGFRs and subsequent ERKs and AKT activation. The gene discussed is FGF1; the disease is breast carcinoma.